You are here

Notice of final decisions to amend (or not amend) the current Poisons Standard, May 2020

Scheduling medicines and poisons

7 May 2020

This web publication constitutes a notice for the purposes of regulation 42ZCZS and regulation 42ZCZX of the Therapeutic Goods Regulations 1990 (the Regulations). In accordance with regulations 42ZCZS and 42ZCZX, this notice publishes:

  1. the decisions made by a delegate of the Secretary pursuant to regulations 42ZCZR and 42ZCZU;
  2. the reasons for those final decisions; and
  3. the date of effect of those decisions.

Final decisions and reasons

How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open it from there.

We aim to provide documents in an accessible format. If you're having problems using this document, please contact medicines.scheduling@health.gov.au (for substances referred to the ACMS or Joint ACCS-ACMS) or chemicals.scheduling@health.gov.au (for substances referred to the ACCS).

Contents

  • 1 Final decisions made pursuant to regulation 42ZCZR – proposals referred to the November 2019 Advisory Committee on Medicines Schedule (ACMS #28)
    • 1.1. Final decision in relation to Sumatripan
    • 1.2. Final decision in relation to Zolmitriptan
    • 1.3. Final decision in relation to Mometasone
    • 1.4. Final decision in relation to calcifediol monohydrate
    • 1.5. Final decision in relation to Paracetamol (liquid formulations)
    • 1.6. Final decision in relation to Paracetamol + ibuprofen
    • 1.7. Final decision in relation to Hyoscine butylbromide
    • 1.8. Final decision in relation to Lidocaine
  • 2 Final decisions made pursuant to regulation 42ZCZR – proposals referred to the November 2019 Joint Advisory Committee on Medicines and Chemicals Scheduling (ACCS-ACMS #23)
    • 2.1. Final decision in relation to Caffeine
    • 2.2. Final decision in relation to N-methyl-2-pyrrolidone (NMP)
  • 3 Final decisions made pursuant to regulation 42ZCZR – proposals referred to the November 2019 Advisory Committee on Chemicals Scheduling (ACCS #26)
    • 3.1. Final decision in relation to Carbon monoxide
    • 3.2. Final decision in relation to Momfluorothrin
    • 3.3. Final decision in relation to Tetraniliprole
    • 3.4. Final decision in relation to Methiozolin
    • 3.5. Final decision in relation to Lambda-cyhalothrin
  • 4 Final decision(s) (without interim decision) made pursuant to regulation 42ZCZU
    • 4.1. Final decision in relation to Acequinocyl
    • 4.2. Final decision in relation to Agrobacterium radiobacter (Rhizobium rhizogenes)
    • 4.3. Final decision in relation to Nonanoic acid
  • 5 Notice of an amendment to the current Poisons Standard in relation to Modified-release (MR) paracetamol
    • 5.1. Decision in relation to modified-release (MR) paracetamol